Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company.
Aurealis Pharma has raised €6.9M across 1 funding round from 1 investor, most recently a Series B round in Jan 2019. Based in Kuopio, Finland; founded 2010; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€6.9M
€6,921,643
Funding rounds
1
Investors
1
distinct backers
Active since
2019-01
latest 2019-01
Funding by year
EUR raised per yearAurealis Pharma — funding by year — interactive chart.
Data table
| Aurealis Pharma — funding by year | |
|---|---|
| 2018 | €6.9M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series B | €6.9M | Finnvera Venture Capital | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData